Correction: Phase II evaluation of zanubrutinib plus R-CHOP for untreated diffuse large B-cell lymphoma with a specific gene alteration
-
By
-
Qunling Zhang
-
Shiyu Jiang
-
Ran Wei
-
Wenhao Zhang
-
Longlong Bao
-
Yizhen Liu
-
Jia Jin
-
Fangfang Lv
-
Chuanxu Liu
-
Xiaojian Liu
-
Hui Sun
-
Jiachen Wang
-
Rong Tao
-
Xiaoyan Zhou
-
Junning Cao
-
November 5, 2026